It Turns out that p53 is Destroyed in a Whole New Way

CSHL scientists have discovered that a protein called BRD8 goes out of control in glioblastoma, paralyzing P53. The discovery could help turn this deadly cancer into a treatable disease.

Crispr/Cas9 Platform Developed Maize Mutant Library Covering 800 Functional Genes with CRISPR/Cas9 Technology

Microbiosci Has Established Automated Microbial Strains Breeding and Screening Platform

Microbialtec Utilized Two Methods to Achieve Pseudomonas Aeruginosa Genome Editin

Form Bio joins PacBio Compatible Program to Accelerate Gene Therapy Research from Data to Insights

Form Bio is a cutting-edge research and discovery platform for individuals and enterprises in life sciences. With an accessible, comprehensive and collaborative platform, Form Bio empowers scientists to efficiently and effectively harness the proliferation of data and computing power that has transformed the science of discovery. Form offers end-to-end integration of the discovery process with intuitive and easy-to-use software applications, combined with an open and adaptable collaborative environment. For more information on Form Bio, visit www.formbio.com

Form Bio joins PacBio Compatible Program to Accelerate Gene Therapy Research from Data to Insights

Form Bio, the provider of advanced computational life sciences technology today announced it has joined the PacBio Compatible program. As part of the program, the Form Bio platform has been verified as compatible with PacBio’s HiFi sequencing solutions, empowering corporate and academic research teams with a dramatically streamlined path from HiFi read data to breakthrough insights.

Integrated DNA Technologies Launches New Archer™ FUSIONPlex™ Core Solid Tumor Panel for Cancer Research

New panel leverages Anchored Multiplex PCR (AMP™) chemistry and Archer Analysis to detect fusions, splice variants and more, enabling downstream application of precision medicine

Patent Issued for AI-Enabled Predictive Risk Rating Capability of Clearwater’s IRM|Analysis® Software

Innovative Application of Artificial Intelligence and Machine Learning Gives Healthcare Organizations Additional Capabilities to Stop Threat Actors by Enabling Them to Make Better Cyber Risk Decisions

CureSearch to fund new cutting-edge study for rare blood cancer in children

Elvin Wagenblast, PhD, of The Tisch Cancer Institute at Mount Sinai, received a CureSearch Young Investigator Award to develop a better understanding of AML in order to guide treatment for patients where standard chemotherapy is ineffective. The study is investigating how a normal blood stem cell can become cancerous. Dr. Wagenblast’s team is using state-of-the-art genome editing to understand vulnerabilities of the disease like never before.

Domainex secures a prestigious King’s Award for Enterprise

Domainex is honoured to announce it has received a King’s Award for Enterprise: International Trade 2023.

Upperton increases oral dosage form capabilities at its Nottingham HQ

Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions (Upperton) has expanded its oral dosage form capabilities at its newly built headquarters in Nottingham, UK.

Tesis Biosciences Announces a Novel Pharmacogenomics Test Enabling Precise, Personalized Response to Wide Range of Pharmaceuticals

Tesis Biosciences Announces a Novel Pharmacogenomics Test Enabling Precise, Personalized Response to Wide Range of Pharmaceuticals

OM1 Unveils Patented, AI-powered Platform to Accelerate Personalized Medicine

OM1, a real-world data, outcomes, and technology company, launched PhenOM, a new AI solution, which gathers patient data points/phenotypes from structured and unstructured datasets – including clinical notes from messy EHRs – to create unique “fingerprints” for patients based on their medical history. With billions of data points from more than 300 patients, PhenOM is delivering personalized care from life science research to point-of-care clinical decision making.

Verana Health Announces the Qdata Parkinson’s Disease Module at 2023 AAN Annual Meeting

Verana Health Announces the Qdata Parkinson’s Disease Module at 2023 AAN Annual Meeting

Results from New Studies Support Role of Digital Tools in Streamlining Dementia Detection; Findings to be Revealed at American Academy of Neurology's Annual Meeting

Linus Health, a digital health company focused on early detection of Alzheimer’s and other dementias, today announced the results of two new studies that further demonstrate the ability of digital cognitive assessments to identify early signs of cognitive impairment and dementia. The findings, which researchers will present at the American Academy of Neurology’s (AAN) 75th Annual Meeting, show that digital, AI-enhanced assessments can play a major role in helping providers efficiently assess older patients’ cognitive function and intervene early in the face of issues - a rising need as new treatments targeting early-stage Alzheimer’s disease become available.

Virscio Deploys Proscia’s Software To Improve Efficiency Of Drug Research And Development

Cloud-based digital pathology platform helps CRO deliver more informed preclinical studies

Creative Biostructure Enhanced Its Thermal Gravimetric Analysis Service

Samsung Biologics Reports First Quarter 2023 Financial Results

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2023.

Peptidoglycan Structure Analysis Now Available at CD BioGlyco

Clearwater Enhances Vendor Cybersecurity Risk Assessment Managed Service Program and CMMC Compliance Certification Capabilities with Cyturus® Software Tools

Clearwater, a cybersecurity and privacy provider, is adopting the Cyturus Third Party Risk Management (TPRM) module of Compliance & Risk Tracker (CRT) as the primary platform for its Vendor Risk Management managed services program, meaning healthcare providers can now better assess and manage third- and fourth-party cybersecurity risk. In 2022, nine of the ten largest healthcare data breaches were caused by third-party vendors. Third-party cybersecurity concerns are consistently cited by Clearwater’s healthcare clients as a key risk to their businesses, leading the company to help solve this challenge by providing an affordable and consistent way of identifying and managing third-party risk.